Search Results - Mei Pan
- Showing 1 - 2 results of 2
-
1
A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context by Qiang Wen, Hao Yu, Mei Pan, Hongtu Chao, Yuhua Gao, Shuhuai Niu, Hongqin Zhao, Youguo Chen, Jianqing Zhu
Published 2025-07-01
Article -
2
Environmental arsenic hijacks DDX5-mediated FANCA splicing to impair R-loops resolution and drive ovarian aging by Tuo Zhang, Jin Niu, Lu Yang, Yuanyuan Yu, Meina He, Changfa Wu, Zengmei Cheng, Mei Pan, Zerui Hong, Jian Sun, Yuan Gao, Tengxiang Chen, Zhengrong Wang, Wei Pan
Published 2025-09-01
Article